Biosante Pharmaceuticals shares owned by Principal Financial Group
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Principal Financial Group
from 13F filings
Historical chart of Principal Financial Group investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Principal Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.4M | 90k | 59.66 |
| 2024-06-30 | $5.4M | 84k | 63.68 |
| 2024-03-31 | $6.1M | 88k | 69.13 |
| 2023-12-31 | $4.5M | 81k | 55.14 |
| 2023-09-30 | $5.1M | 89k | 58.06 |
| 2023-06-30 | $4.4M | 82k | 53.83 |
| 2023-03-31 | $3.0M | 77k | 39.72 |
| 2022-12-31 | $3.1M | 78k | 40.23 |
| 2022-09-30 | $2.5M | 79k | 32.14 |
| 2022-06-30 | $2.7M | 93k | 29.05 |
| 2022-03-31 | $2.5M | 88k | 28.11 |
| 2021-12-31 | $3.6M | 78k | 46.07 |
| 2021-09-30 | $2.2M | 66k | 32.82 |
| 2021-06-30 | $2.4M | 69k | 35.05 |
| 2021-03-31 | $2.7M | 75k | 36.14 |
| 2020-12-31 | $2.2M | 74k | 29.04 |
| 2020-09-30 | $2.2M | 76k | 28.21 |
| 2020-06-30 | $2.4M | 75k | 32.33 |
| 2020-03-31 | $3.3M | 81k | 40.75 |
| 2019-12-31 | $5.2M | 84k | 61.67 |
| 2019-09-30 | $5.6M | 78k | 72.88 |
| 2019-06-30 | $5.9M | 72k | 82.20 |
| 2019-03-31 | $4.7M | 67k | 70.53 |
| 2018-12-31 | $3.0M | 67k | 45.02 |
| 2018-09-30 | $3.8M | 67k | 56.54 |
| 2018-06-30 | $4.7M | 71k | 66.80 |
| 2018-03-31 | $4.0M | 69k | 58.22 |
| 2017-12-31 | $4.3M | 67k | 64.45 |
| 2017-09-30 | $3.5M | 68k | 52.49 |
| 2017-06-30 | $2.9M | 61k | 46.79 |
| 2017-03-31 | $3.4M | 68k | 49.51 |
| 2016-12-31 | $4.0M | 66k | 60.63 |
| 2016-09-30 | $3.8M | 58k | 66.35 |
| 2016-06-30 | $3.0M | 53k | 55.81 |
| 2016-03-31 | $1.7M | 52k | 33.65 |
| 2015-12-31 | $2.3M | 50k | 45.12 |
| 2015-09-30 | $1.9M | 48k | 39.52 |
| 2015-06-30 | $3.1M | 50k | 62.04 |
| 2015-03-31 | $3.2M | 51k | 62.55 |